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Summary 
1 2 3 4
The effect of implant dosing pattern on anabolic 
response was evaluated in predominately Angus 
steers (n=192).  Steers, except the control, were 
implanted with 1 of 3 different implant strategies.  
Cumulatively all implant treatments received a 
dose of 24 mg estradiol 17-β (E2) and 120 mg 
trenbolone acetate (TBA).  Dosing patterns were 
8 mg E2 and 40 mg TBA given 3 times; 12 mg E2 
and 60 mg TBA given 2 times or 24 mg E2 and 
120 mg TBA given 1 time.  Implanted cattle had 
heavier body weights, increased average daily 
gain, and lower feed conversion compared to 
non-implanted controls.  There were no 
differences among the implant treatments for 
cumulative 133 d body weight gain or average 
daily gain.  Carcass quality was not affected by 
implant or implant dosing pattern.  Dosing pattern 
did have an affect on growth patterns.    
 
Introduction 
  
There has been a great deal of research 
conducted to determine the optimum anabolic 
dose needed to maximize anabolic response.  
However, research is limited in establishing the 
threshold dose needed to stimulate anabolic 
response and determine if implant dosing 
patterns affect anabolic response.    For this 
experiment, multiple low doses of anabolic  
hormones were given in an effort to sustain 
anabolic concentrations.  A comparison could 
then be made between those steers receiving 
multiple low doses of anabolic agents and those 
receiving a single high dose of anabolic agent.  
The objective of this study was to determine the 
effect of implant dosing pattern on finishing steer 
performance and carcass characteristics.   
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Materials and Methods 
 
Predominately Angus steers (n=192) which were 
previously in a backgrounding experiment, were 
assigned to this experiment.  Steers had been 
vaccinated and treated for parasites prior to 
initiation of the backgrounding experiment.  The 
steers were not implanted during the 
backgrounding experiment.    
 
All implant treatments were designed to provide a 
cumulative dose of 24 mg of estradiol 17-β (E2) 
and 120 mg of trenbolone acetate (TBA).  The 4 
treatments evaluated were 1) no implant control; 
2) 8 mg E2 and 40 mg TBA administered on days 
0, 42 and 84; 3) 12 mg E2 and 60 mg TBA 
administered on days 0 and d 63; and 4) 24 mg 
E2 and 120 mg TBA administered on day 0 
(Table 1). 
Table 1: List of Implant Treatments 
 Treatments  
 1 2 3 4 
 E2:TBA, mg 
Day     
0  -- 8:40 12:60 24:120 
42  -- 8:40 -- -- 
63 -- -- 12:60 -- 
84  -- 8:40 -- -- 
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Steers were stratified by body weight, separated 
into two weight categories (light 774 ± 63 lb and 
heavy 867± 49 lb) and randomly assigned within 
each weight category to an implant treatment 
during a 20 d pre-test phase.  Cattle were 
acclimated to the final diet by day 0.  The lighter 
group was started on experiment 14 d after the 
heavier group.  A total of 24 pens were used (8 
steers/pen and 3 pens/treatment within each 
weight category).  Steers were stepped up from a 
45% roughage diet to the final diet using a 4-step 
process.  The roughage source for the final diet 
was initially corn silage; this was replaced by oat 
hay at d 98 for the heavy group and d 84 for the 
light group.  All treatments were fed similarly 
(Table 2) except that for the last 21 days on feed, 
oatlage replaced oat hay for the lighter group 
only.  Feed ingredients were assayed weekly and 
DMI and diet composition (except NEm and NEg) 
were calculated from the laboratory values.  
 
 
Table 2: Formulations and Compositions of Finishing Dietsa  
 Dietsb
 1 2 
Corn silage  5.92 -- 
Oat hayc -- 3.00 
Whole shell corn 55.15 55.90 
High moisture ear corn  26.83 28.70 
Soybean meal 7.80 8.30 
Liquid supplementd 4.30 4.10 
 100.0 100.0 
   
DMe 71.0 81.0 
CPe 12.5 13.1 
NDFe 13.2 13.5 
NEm, Mcal/cwtf 92.0 92.4 
NEg, Mcal/cwtf 61.4 61.5 
aDM basis. 
bDiet 1 was fed until d 98 (heavy group )and d 84 (light group) when diet 
2 was fed.  
cReplaced with oat silage for the lighter group at 112 d on feed. 
dProvided monensin at 29 g/T and urea at 0.76% of final diet; supplied 
minerals and vitamins to meet or exceed nutrient requirements (NRC, 
2000).   
eCalculated from lab assays 
fCalculated from tabular values 
 
 
Body weights were recorded prior to feeding 
every 21 d except the final weight which was at a 
28 d interval.  The final body weight was recorded 
in the morning and cattle were shipping that 
evening to Tyson Fresh Meats, Dakota City, NE.  
Slaughter occurred the following morning and 
individual cattle identity was tracked through the 
slaughter process.  Carcass data were collected 
approximately 30 h after slaughter.  Hot carcass 
weight was recorded and ribeye area and 
subcutaneous rib fat were measured.  Marbling 
scores and KPH fat, (%) were assigned by an 
USDA grader, Yield Grade was calculated from 
the carcass values collected.  Three calves were 
realized and removed from the data for reasons 
not related to treatments.  Carcass data were not 
captured on 9 steers.   
 
Data were analyzed as a completely random 
design with a 2 x 4 factorial arrangement of 
treatments with factors of weight group and 
implant treatment.  Steer performance was 
analyzed using pen as the experimental unit.  
Carcass data were analyzed using the individual 
as the experimental unit.  All performance and 
carcass variables were analyzed using the 
General Linear Model (GLM) procedure of SAS.  
If the GLM evaluation of treatment was significant 
(P < 0.05) then treatment means were separated 
using Fishers T test.   
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Results and Discussion 
 
The interim performance is summarized by weigh 
dates (Table 3) and cumulative intervals (Table 4) 
corresponding to implant dates.  Only main 
effects of treatment are reported as no weight 
group x treatment interaction occurred.  The 
cumulative intervals depict how growth curves 
responded to implant dosages.  During the first 
42 d, implants did not affect (P = 0.1082) ADG or 
DMI but F/G was lower (P < 0.05) for implanted 
cattle.   
 
Table 3: Interim Performance by Treatmenta  
 Treatment 
 1 2 3 4 SEM 
Implant dose 
(E2:TBA), mg  --  8:40 12:60 24:120  
     Frequency              --         3           2         1  
Initial BW 817 818 821 825 2.96 
      
1 to 21 d      
    BW, lb 887 896 898 905 4.52 
    ADG, lb 3.37 3.70 3.64 3.79 0.19 
    DMI, lb 19.50 19.66 19.31 19.83 0.44 
    F/G 5.95 5.56 5.41 5.33 0.23 
      
22 to 42 d      
    BW, lb 984b 997bc 1000bc 1018c 7.24 
    ADG, lb 4.59 4.84 4.86 5.37 0.21 
    DMI, lb 22.05 22.18 21.68 22.71 0.59 
    F/G 4.87b 4.61bc 4.49c 4.26c 0.12 
      
43 to 63 d      
    BW, lb 1056b 1074bc 1073bc 1093c 7.67 
    ADG, lb 3.43 3.63 3.46 3.61 0.19 
    DMI, lb 22.96 23.61 22.76 24.09 0.47 
    F/G 6.77 6.64 6.71 6.79 0.32 
      
64 to 84 d      
    BW, lb 1119b 1146c 1149c 1164c 6.97 
    ADG, lb 3.01b 3.44c 3.64c 3.35bc 0.15 
    DMI, lb 23.24 24.01 23.21 24.47 0.44 
    F/G 7.78 7.04 6.42 7.56 0.43 
      
85 to 105 d      
    BW, lb 1195b 1233c 1235c 1239c 7.98 
    ADG, lb 3.64 4.17 4.07 3.60 0.21 
    DMI, lb 23.76b 25.13cd 24.20bc 25.54d 0.38 
    F/G 6.74 6.03 6.03 7.32 0.39 
      
106 to 133 d      
    BW, lb 1267b 1326c 1319c 1329c 7.84 
    ADG, lb 2.56b 3.32c 3.01bc 3.20c 0.16 
    DMI, lb 23.29b 25.46cd 24.48bc 25.89d 0.40 
    F/G 9.15 7.73 8.29 8.31 0.44 
aCalculated using unshrunk live body weight. 
b,c,dMeans in the same row without a common superscript differ (P < 0.05). 
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Table 4: Cumulative Intervals of Steer Performance Corresponding to Implantinga
 Treatments 
 1 2 3 4 SEM 
Implant dose 
(E2:TBA), mg -- 8:40 12:60 24:120  
     Frequency -- 3 2 1  
1 to 42 d      
   ADG, lb 3.98 4.27 4.25 4.58 0.16 
   DMI, lb 20.77 20.92 20.49 21.27 0.47 
   F/G 5.22b 4.91c 4.83c 4.68c 0.10 
      
43 to 83 d      
   ADG, lb 3.22 3.54 3.55 3.48 0.13 
   DMI, lb 23.10 23.81 22.98 24.28 0.44 
   F/G 7.23 6.81 6.49 7.13 0.29 
      
1 to 63 d      
   ADG, lb 3.80b 4.06b 3.99b 4.25c 0.11 
   DMI, lb 21.50 21.82 21.25 22.21 0.40 
   F/G 5.67b 5.41c 5.34c 5.23c 0.09 
      
64 to 133 d      
   ADG, lb 3.02b 3.61c 3.52c 3.36c 0.11 
   DMI, lb 23.42b 24.93cd 24.01bc 25.36d 0.35 
   F/G 7.80b 6.92cd 6.84d 7.60bc 0.25 
      
1 to 84 d      
   ADG, lb 3.60b 3.90c 3.90c 4.03c 0.07 
   DMI, lb 21.94 22.37 21.74 22.77 0.38 
   F/G 6.10b 5.76c 5.58c 5.66c 0.08 
      
85 to 133 d      
   ADG, lb 3.02b 3.68c 3.47c 3.37bc 0.13 
   DMI, lb 23.49b 25.32cd 24.36bc 25.74d 0.38 
   F/G 7.83b 6.90d 7.07cd 7.68bc 0.24 
      
1 to 133 d      
   ADG, lb 3.39b 3.82c 3.74c 3.79c 0.06 
   DMI, lb 22.51b 23.45cd 22.70bc 23.87d 0.33 
   F/G 6.65b 6.15c 6.07c 6.31c 0.08 
aCalculated using unshrunk live body weight. 
b,c,dMeans in the same row without a common superscript differ (P < 0.05). 
 
 
From d 1 to 63, implanted cattle had lower 
(P < 0.05) F/G compared to non-implanted 
cattle; with cattle in treatment 4 having greater 
(P < 0.05) ADG compared to other treatments. 
From d 64 to 133, implant treatments caused 
increased (P < 0.05) ADG, treatments 2 and 4 
tended to have increased (P < 0.10) DMI 
compared to control and treatment 3.  After the 
second anabolic dose was given to cattle in 
treatment 3 (d 64 to 133), F/G was decreased 
(P < 0.05) compared to cattle in treatment 4.  
Treatment 2 tended to decrease (P < 0.10) F/G 
compared to treatment 4.  After the third anabolic 
dose was given to treatment 2 (d 85 to 133), F/G 
was decreased (P < 0.05) compared to 
treatment 4 and treatment 3 tended to have 
reduced (P < 0.10) F/G compared to treatment 
4. 
 
Implant treatments had increased (P < 0.05) 
cumulative carcass adjusted ADG compared with 
control steers (Table 5).  Dosing pattern did not 
affect (P > 0.05) cumulative carcass adjusted 
ADG among implant treatments.  Cumulatively, 
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treatments 2 and 4 caused increased (P < 0.05) 
DMI compared to control.  Cumulative DMI for 
treatment 3 was similar (P > 0.05) to the control 
and lower (P < 0.05) compared to treatment 4.  
Treatment 2 and 3 caused decreased (P <. 0.05) 
cumulative carcass adjusted F/G compared to 
control.   Since cumulative ADG did not differ 
among implant treatments, the decrease (P < 
0.05) in cumulative carcass adjusted F/G for 
treatment 3 compared to treatment 4 is probably 
accounted for by decreased DMI.  
 
Although dosing pattern did not cause a 
difference in cumulative ADG it did affect the 
pattern of growth.  For the first 63 d (Table 4) the 
change in ADG relative to control was 6.8, 5.0 
and 11.8% for treatment 2, 3 and 4, respectively.  
From d 64 to 133, the response was 19.5, 16.6 
and 11.3%, respectively.  The response was 
21.9, 14.9 and 11.6%, respectively, from d 85 to 
133.  Cattle receiving multiple low doses of E2 
and TBA seemed to have a slower decline in 
growth as days on feed increased verses those 
cattle receiving a single dose of E2 and TBA 
(Figure 1). 
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Figure 1.  The effect of implants on improvement in ADG relative to cattle which were not 
implanted.  Treatment 1 = control; Treatment 2 = 3 doses 8 mg E2 and 40 mg TBA ; 
Treatment 3 = 2 doses 12 mg E2 and 60 mg TBA; Treatment 4 = 24 mg E2 and 120 mg 
TBA.  a, b Means in the same group without a common superscript differ (P < 0.05). 
a
b
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Repeated administration of anabolic doses 
appears to sustain the anabolic response.  The 
response in F/G (calculated using live, unshrunk 
body weight) to dosing pattern is more evident 
when F/G is viewed as % over controls (Figure 
2).  From d 1 to 63 the improvement in F/G 
relative to control was 4.6, 5.8 and 7.8% for 
treatment 2, 3, and 4, respectively.  From d 64 to 
133 the response was 11.3, 12.3 and 2.6%, 
respectively.  From d 85 to 133, the % F/G 
improvement over controls was 11.9, 9.7 and 
1.9% respectively. 
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Figure 2.  The effect of implants on improvement in F/G relative to cattle which were not implanted.  
Treatment 1 = control; Treatment 2 = 3 doses 8 mg E2 and 40 mg TBA ; Treatment 3 = 2 doses 12 
mg E2 and 60 mg TBA; Treatment 4 = 24 mg E2 and 120 mg TBA.  a, b Means in the same group 
without a common superscript differ (P < 0.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Implanting increased (P < 0.05) carcass weight 
an average of 33 lb (Table 5).  Treatments 3 and 
4 had an increased (P < 0.05) ribeye area 
compared to control.  Yield Grade and marbling 
score were not affected by treatment (P > 0.15) 
while KPH fat tended (P < 0.10) to be lower for 
treatment 2.  Two important points should be 
made when the effects of implants on Quality 
Grades are considered for this study.  The first 
being that these cattle had exceptionally high 
overall Quality Grades and the marbling response 
to implants seen in this experiment may not be 
typical of all cattle.  Secondly, this experiment 
was designed to target anabolic activity when 
caloric intake was not limited.  When adaptation 
to diet does not occur prior to implanting, 
outcomes may be different.   
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 Table 5: Cumulative Steer Performance and Carcass Characteristics by Treatmenta
 Treatment 
 1 2 3 4 SEM 
133 d Cumulative      
Adjusted end wtb 1233d 1283e 1289e 1285e 8.69 
ADG, lb 3.13d 3.49e 3.52e 3.45e 0.06 
DMI, lb 22.51b 23.45cd 22.70bc 23.87d 0.33 
F/G 7.19d 6.73ef 6.46f 6.93de 0.12 
      
Hot carcass wt, lb 771d 802e 806e 803e 7.53 
Dress, % 60.84de 60.42d 61.09e 60.41d 0.002 
      
Ribeye area, in2 12.70d 13.00de 13.36e 13.30e 0.19 
Ribfat depth, in 0.49 0.47 0.52 0.55 0.02 
KPH, % 1.95 1.70 1.84 1.76 0.007 
Marbling scorec 6.41 6.17 6.31 6.16 0.16 
Yield Grade 2.99 2.91 2.96 3.03 0.07 
Choice or better, % 91.1 90.7 87.2 82.2  
aLeast squares means.      
bCalculated as hot carcass wt ÷ 0.625. 
cSmall0 = 5; Modest0 = 6. 
d,e,fMeans in the same row without a common superscript differ (P < 0.05). 
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